Advertisement
Advertisement
U.S. Markets open in 6 hrs 2 mins
S&P Futures
4,037.25 +4.75 (+0.12%) Dow Futures
33,811.00 +26.00 (+0.08%) Nasdaq Futures
11,969.50 +1.50 (+0.01%) Russell 2000 Futures
1,897.10 +3.60 (+0.19%) Crude Oil
77.23 -0.67 (-0.86%) Gold
1,924.80 -14.40 (-0.74%)
At close: 04:03PM EST
After hours:
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
| Previous Close | 43.79 |
| Open | 43.79 |
| Bid | 0.00 x 3200 |
| Ask | 0.00 x 1300 |
| Day's Range | 43.40 - 44.13 |
| 52 Week Range | 41.45 - 56.32 |
| Volume | |
| Avg. Volume | 21,520,290 |
| Market Cap | 244.44B |
| Beta (5Y Monthly) | 0.64 |
| PE Ratio (TTM) | 25.51 |
| EPS (TTM) | 1.71 |
| Earnings Date | Feb 06, 2023 - Feb 10, 2023 |
| Forward Dividend & Yield | 1.60 (3.51%) |
| Ex-Dividend Date | Nov 03, 2022 |
| 1y Target Est | N/A |
- CoinDesk
VitaDAO Closes $4.1M Funding Round With Pfizer Ventures for Longevity Research
The decentralized autonomous organization is raising funds for research on technologies that target human aging.
- Investor's Business Daily
Moderna Scores A Win In RSV — But Its Shares Don't Reflect That
The Food and Drug Administration granted Moderna's experimental RSV vaccine an expedited review, but Moderna stock dipped Monday.
- Motley Fool
Down 14.5%, Is Pfizer Stock a Screaming Buy?
Pfizer's declining COVID-19 franchise and upcoming patent expirations have weighed heavily on its stock.
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
© 2023 Yahoo. All rights reserved.
